Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06331377 · ClinicalTrials.gov registry record
Clinical and Molecular Characteristics of Histiocytic Disorders
A clinical trial of Histiocytic Disorder, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT06331377 is a study of Histiocytic Disorder that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06331377, a study of Histiocytic Disorder, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to collect medical and personal histories as well as a samples of blood, other body fluid and/or tumor/disease tissue for current and future research studies on histiocytic disorders.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-07-27 |
| Est. Completion | 2027-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06331377
The ClinicalTrials.gov registry entry for NCT06331377 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Histiocytic Disorder appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06331377 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06331377 about?
NCT06331377 is a clinical study titled "Clinical and Molecular Characteristics of Histiocytic Disorders". This study is being done to collect medical and personal histories as well as a samples of blood, other body fluid and/or tumor/disease tissue for current and future research studies on histiocytic disorders.
What is the current status of trial NCT06331377?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2017-07-27. Estimated completion is 2027-07-31.
What conditions does trial NCT06331377 study?
This clinical trial studies the following conditions: Histiocytic Disorder.
What interventions are being tested in trial NCT06331377?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06331377?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06331377 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.